Iodide

Iodide

SCHEMBL180142

CCCn1cc[n+](C)c1.[I-]

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.66
MEN1 O00255 2/20 0.66
HSP90AA1 P07900 2/20 0.66
KMT2A Q03164 2/20 0.66
APAF1 O14727 1/20 0.66
NPC1 O15118 1/20 0.66
PLA2G1B P04054 1/20 0.66
MAPT P10636 1/20 0.66
MAPK1 P28482 1/20 0.66
HTT P42858 1/20 0.66
RAB9A P51151 1/20 0.66
NPSR1 Q6W5P4 1/20 0.66
ATG4B Q9Y4P1 1/20 0.66
FDPS P14324 5/20 0.39
LMNA P02545 1/20 0.37
PON1 P27169 2/20 0.34
POLB P06746 1/20 0.32
APOBEC3A P31941 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL293656 0.98
SCHEMBL17139699 0.98 SMN1; SMN2 (0.68) SMN1; SMN2MEN1HSP90AA1KMT2AAPAF1
Bromide SCHEMBL557293 0.95 SMN1; SMN2 (0.71) SMN1; SMN2MEN1HSP90AA1KMT2AAPAF1
Fluoride SCHEMBL28444338 0.95 SMN1; SMN2 (0.66) SMN1; SMN2MEN1HSP90AA1KMT2AAPAF1
Hydrochloric Acid SCHEMBL556929 0.95 SMN1; SMN2 (0.66) SMN1; SMN2MEN1HSP90AA1KMT2AAPAF1
Fluoride Ion SCHEMBL1898574 0.95 SMN1; SMN2 (0.66) SMN1; SMN2MEN1HSP90AA1KMT2AAPAF1
Iodide SCHEMBL3774573 0.95 SMN1; SMN2 (0.66) SMN1; SMN2MEN1HSP90AA1KMT2AAPAF1
Water SCHEMBL28929074 0.95 SMN1; SMN2 (0.66) SMN1; SMN2MEN1HSP90AA1KMT2AAPAF1
SCHEMBL25362454 0.90 SMN1; SMN2 (0.59) SMN1; SMN2MEN1HSP90AA1KMT2AAPAF1
SCHEMBL15732335 0.90 SMN1; SMN2 (0.59) SMN1; SMN2MEN1HSP90AA1KMT2AAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260088410-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS HENKEL AG & CO KGAA (DE) 2026-03-26 US claimed
US-12540262-B2 Two component (2K) curable adhesive composition HENKEL AG & CO. KGAA (DE) 2026-02-03 US claimed
US-12454635-B2 Two component (2K) curable adhesive composition HENKEL AG & CO. KGAA (DE) 2025-10-28 US claimed
EP-4632477-A1 METHOD FOR MANUFACTURING FLEXIBLE ELECTROCHROMIC DEVICE AND FLEXIBLE ELECTROCHROMIC DEVICE MANUFACTURED THEREBY Korea University of Technology and Education Industry - University Cooperation Foundation (KR) 2025-10-15 EP claimed
US-12398302-B2 Two component (2K) curable adhesive composition HENKEL AG & CO. KGAA (DE) 2025-08-26 US claimed
US-20250188048-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) 2025-06-12 US claimed
WO-2025119658-A1 ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM HENKEL AG & CO. KGAA (DE) 2025-06-12 WO claimed
EP-4567085-A1 ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM Henkel AG & Co. KGaA (DE) 2025-06-11 EP claimed
CN-119823109-A An electrochromic material electrochromic composition and electrochromic device 吉林大学 2025-04-15 CN claimed
US-12234330-B2 Method for manufacturing stretchable electrochromic device, and stretchable electrochromic device manufactured thereby KOREA UNIVERSITY OF TECHNOLOGY AND EDUCATION INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2025-02-25 US claimed
US-20070176148-A1 Organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US claimed
WO-2007066087-A2 ELECTROCHEMICAL SYSTEM COMPRISING PHOTOACTIVE ELEMENTS HYDROGEN SOLAR LTD (GB) 2007-06-14 WO claimed
US-7196264-B2 Dye sensitized solar cell and method for manufacturing dye sensitized solar cell KABUSHIKI KAISHA TOSHIBA (JP) 2007-03-27 US claimed
US-20050072462-A1 Solid state dye-sensitized solar cell employing composite polymer electrolyte KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2005-04-07 US claimed
EP-1521277-A2 Solid state dye-sensitized solar cell employing composite polymer electrolyte Korea Institute of Science and Technology (KR) 2005-04-06 EP claimed
EP-1507307-A1 PHOTOELECTRIC CONVERSION DEVICE Hitachi Maxell, Ltd. (JP) 2005-02-16 EP claimed
US-20040238826-A1 Photoelectric conversion device PANASONIC ELECTRIC WORKS CO., LTD. (JP) 2004-12-02 US claimed
US-20040211461-A1 Dye-sensitized solar cell KABUSHIKI KAISHA TOSHIBA (JP) 2004-10-28 US claimed
US-6384321-B1 THAT FORMS AN ONIUM SALT WITH A IMIDAZOLIUM SALT; A HALOGEN CONTAINING COMPOUND; NITROGEN, PHOSPHOROUS OR SULFUR CONTAINING COMPOUND KABUSHIKI KAISHA TOSHIBA (JP) 2002-05-07 US claimed
EP-1087412-A2 Electrolyte composition, photosensitized solar cell using said electrolyte composition, and method of manufacturing photosensitized solar cell KABUSHIKI KAISHA TOSHIBA (JP) 2001-03-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250188048-A1 METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND HPD, DPYD, PGD SMN1; SMN2 4474/4885MEN1 4667/4885HSP90AA1 3762/4885
US-12540262-B2 Two component (2K) curable adhesive composition ILK, MAT2A, MMAB SMN1; SMN2 967/4885MEN1 2290/4885HSP90AA1 265/4885
US-20260088410-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS EPCAM, CDH1, ITGA4 SMN1; SMN2 1845/4885MEN1 2502/4885HSP90AA1 3206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.